HuGE Literature Finder
Records
1
-
18
| Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of oncology 2022 4 2022 1763778. Li Yue, Li Chong, Jiang Ya, Han Xue, Liu Sisi, Xu Xiuxiu, Tang Wanxiangfu, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Xing Minyan, Zhang Yixiang, Wang Yuezh |
| Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1. Clinical lung cancer 2021 4 22 (5): 381-389. Cabezón-Gutiérrez Luis, Custodio-Cabello Sara, Palka-Kotlowska Magda, Alonso-Viteri Soledad, Khosravi-Shahi Parh |
| Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis. Cancer treatment and research communications 2021 5 27 100374. Diez-Calzadilla N A, Noguera Salvá R, Soriano Sarrió P, Martínez-Jabaloyas J |
| Interaction between common variants of MDM2 and PPP1R13L and CD3EAP and TP53 SNPs in relation to lung cancer risk among Chinese. Annals of translational medicine 2020 9 8 (15): 934. Yin Jiaoyang, Hou Wei, Vogel Ulla, Ma Yegang, Wang Chunhong, Wang Huiwen, Sun Zhenxia |
| Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients. The pharmacogenomics journal 2018 Apr . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Valdivia-Bautista Javier, Faus-Dáder María José, Calleja-Hernández Miguel Áng |
| Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population. Asian Pacific journal of cancer prevention : APJCP 2018 Apr 19 (4): 1059-1062. Yilmaz Meral, Tas Ayca, Donmez Gonca, Kacan Turgut, Silig Yav |
| Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx. Oral oncology 2016 May 56 78-83. Feng Yun, Li Yuncheng, Zhang Yang, Zheng Hongliang, Li Guoj |
| Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis. Medicine 2016 Mar 95 (12): e2941. Ding Hui, Dai Yu, Ning Zhongyun, Fan Ning, Wang Zhiping, Li Pei, Zhang Liyuan, Tao Yan, Wang Hanzha |
| Germline genetics of the p53 pathway affect longevity in a gender specific manner. Current aging science 2014 7 (2): 91-100. Groß Sebastian, Immel Uta-Dorothee, Klintschar Michael, Bartel Fra |
| MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer. Oral oncology 2012 Jul 48 (7): 602-7. Vivenza Daniela, Gasco Milena, Monteverde Martino, Lattanzio Laura, Syed Nelofer, Colantonio Ida, Denaro Nerina, Natoli Guido, Comino Alberto, Russi Elvio, Merlano Marco, Crook Tim, Lo Nigro Cristia |
| MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. Molecular carcinogenesis 2011 Jun 50 (6): 433-8. Dong Jing, Ren Binhui, Hu Zhibin, Chen Jiaping, Hu Lingmin, Dai Juncheng, Jin Guangfu, Xu Lin, Shen Hongbi |
| Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2011 Jan 15 (1): 48-56. Boonstra Jurjen J, van Marion Ronald, Tilanus Hugo W, Dinjens Winand N |
| MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia. European journal of haematology 2010 Sep 85 (3): 251-6. Willander Kerstin, Ungerbäck Jonas, Karlsson Karin, Fredrikson Mats, Söderkvist Peter, Linderholm Ma |
| Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 May 15 (10): 3550-6. Toffoli Giuseppe, Biason Paola, Russo Antonio, De Mattia Elena, Cecchin Erika, Hattinger Claudia Maria, Pasello Michela, Alberghini Marco, Ferrari Cristina, Scotlandi Katia, Picci Piero, Serra Massi |
| p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 May 15 (9): 3103-9. Cescon David W, Bradbury Penelope A, Asomaning Kofi, Hopkins Jessica, Zhai Rihong, Zhou Wei, Wang Zhaoxi, Kulke Matthew, Su Li, Ma Clement, Xu Wei, Marshall Ariela L, Heist Rebecca Suk, Wain John C, Lynch Thomas J, Christiani David C, Liu Geoffr |
| Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations. BMC cancer 2009 9 (1): 60. Nechushtan Hovav, Hamburger Tamar, Mendelson Susan, Kadouri Luna, Sharon Nir, Pikarsky Eli, Peretz Tam |
| Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncology reports 2008 Jul 20 (1): 49-55. Horikawa Yohei, Nadaoka Junichi, Saito Mitsuru, Kumazawa Teruaki, Inoue Takamitu, Yuasa Takeshi, Tsuchiya Norihiko, Nishiyama Hiroyuki, Ogawa Osamu, Habuchi Tomono |
| Association of breast cancer outcome with status of p53 and MDM2 SNP309. Journal of the National Cancer Institute 2006 Jul 98 (13): 911-9. Boersma Brenda J, Howe Tiffany M, Goodman Julie E, Yfantis Harry G, Lee Dong H, Chanock Stephen J, Ambs Stef |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: